| Popis: |
M. Sandler: Introduction S. J. Peroutka & A. W. Schmidt: An overview of 5-hydroxytryptamine receptor families D. L. Murphy: An overview of serotonin neurochemistry and neuroanatomy M. B. H. Youdim: Milacemide: a neuropsychotropic glycine prodrug that potentiates serotonergic activity P. C. Waldmeier & L. Maitre: The inactive enantiomer of a noradrenaline uptake blocker reduces 5-HT synthesis H. Y. Meltzer & R. C. Arora: Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality? V. Glover, J. Jarman, & M. Sandler: The role of 5-HT in migraine: disentangling the links with depression G. F. Oxenkrug: The acute effect of monoamine oxidase inhibitors on serotonin conversion to melatonin G. F. Oxenkrug, P. Requintina, I. M. McIntyre, & R. Davis: Stimulation of rat pineal melatonin synthesis by a single electroconvulsive shock G. Racagni, D. Tinelli, E. Bianchi, N. Brunello, & J. Perez: cAMP-dependent binding proteins and endogenous phosphorylation after anti-depressant treatment P. J. Cowen & I. M. Anderson: Abnormal 5-HT neuroendocrine function in depression: association or artefact? J. Deakin: Experimental tests of the 5-HT imbalance theory of affective disturbance D. S. Robinson: Antidepressant efficacy of 5-HTO 1A partial agonist drugs J. J. Lopez-Ibor Jr, J. Saiz-Ruiz, L. Moral, I. Moreno, & R. Vinas: Neuroendocrine serotonergic challenges in clinical research M. Briley & P. Chopin: Serotonin in anxiety: evidence from animal models C. Curzon, G. A. Kennett, & P. Whitton: Anxiogenic effect of the 5-HTO1C agonist m - chlorophenylpiperazine M. Palfreyman & J. H. Kehne: Does 5-hydroxytryptamine have a role in anxiety and the action of anxiolytics? T. R. Insel: Serotonin in obsessive-compulsive disorder: a casual connection or more monomania about a major monoamine? M. Linnoila: Monoamines, glucose metabolism, and impulse control G. Curzon: 5-Hydroxytryptamine in the control of feeding and its possible implications for appetite disturbance B. Guardiola-Lemaitre: d-Fenfluramine and animal models of eating disorders C. G. Gottfries: Disturbance of the 5-hydroxytryptamine metabolism in ageing and in Alzheimer's and vascular dementias M. G. Palfreyman, S. M. Sorenson, A. A. Carr, H. C. Cheng, & M. W. Dudley: 5-HTO3 receptor antagonists and their potential in psychiatric disorders H. Y. Meltzer: Atypical antipsychotic drugs: the 5HTO2/DAO2 ratio A. Carlsson: Closing remarks Index. |
